312 related articles for article (PubMed ID: 12734202)
1. The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.
McRobert EA; Gallicchio M; Jerums G; Cooper ME; Bach LA
J Biol Chem; 2003 Jul; 278(28):25783-9. PubMed ID: 12734202
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end-products induce calpain-mediated degradation of ezrin.
McRobert EA; Young AN; Bach LA
FEBS J; 2012 Sep; 279(17):3240-50. PubMed ID: 22805611
[TBL] [Abstract][Full Text] [Related]
3. Localization of the ezrin binding epitope for glycated proteins.
McRobert EA; Tikoo A; Gallicchio MA; Cooper ME; Bach LA
Ann N Y Acad Sci; 2005 Jun; 1043():617-24. PubMed ID: 16037285
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association.
Matsui T; Maeda M; Doi Y; Yonemura S; Amano M; Kaibuchi K; Tsukita S; Tsukita S
J Cell Biol; 1998 Feb; 140(3):647-57. PubMed ID: 9456324
[TBL] [Abstract][Full Text] [Related]
5. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family.
Reczek D; Berryman M; Bretscher A
J Cell Biol; 1997 Oct; 139(1):169-79. PubMed ID: 9314537
[TBL] [Abstract][Full Text] [Related]
6. Localization of the ezrin binding epitope for advanced glycation endproducts.
McRobert EA; Tikoo A; Cooper ME; Bach LA
Int J Biochem Cell Biol; 2008; 40(8):1570-80. PubMed ID: 18203644
[TBL] [Abstract][Full Text] [Related]
7. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
Maresso AW; Baldwin MR; Barbieri JT
J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.
Gallicchio MA; McRobert EA; Tikoo A; Cooper ME; Bach LA
J Am Soc Nephrol; 2006 Feb; 17(2):414-21. PubMed ID: 16371434
[TBL] [Abstract][Full Text] [Related]
9. Effects of advanced glycation end products on ezrin-dependent functions in LLC-PK1 proximal tubule cells.
Bach LA; Gallicchio MA; McRobert EA; Tikoo A; Cooper ME
Ann N Y Acad Sci; 2005 Jun; 1043():609-16. PubMed ID: 16037284
[TBL] [Abstract][Full Text] [Related]
10. Soluble ezrin purified from placenta exists as stable monomers and elongated dimers with masked C-terminal ezrin-radixin-moesin association domains.
Bretscher A; Gary R; Berryman M
Biochemistry; 1995 Dec; 34(51):16830-7. PubMed ID: 8527459
[TBL] [Abstract][Full Text] [Related]
11. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.
Nguyen R; Reczek D; Bretscher A
J Biol Chem; 2001 Mar; 276(10):7621-9. PubMed ID: 11106646
[TBL] [Abstract][Full Text] [Related]
12. Functional activities and cellular localization of the ezrin, radixin, moesin (ERM) and RING zinc finger domains in MIR.
Bornhauser BC; Johansson C; Lindholm D
FEBS Lett; 2003 Oct; 553(1-2):195-9. PubMed ID: 14550572
[TBL] [Abstract][Full Text] [Related]
13. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.
McRobert EA; Bach LA
Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cortical structure by the ezrin-radixin-moesin protein family.
Bretscher A
Curr Opin Cell Biol; 1999 Feb; 11(1):109-16. PubMed ID: 10047517
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel intracellular heparanase that has a FERM domain.
Bame KJ; Venkatesan I; Dehdashti J; McFarlane J; Burfeind R
Biochem J; 2002 May; 364(Pt 1):265-74. PubMed ID: 11988100
[TBL] [Abstract][Full Text] [Related]
16. A novel serine-rich motif in the intercellular adhesion molecule 3 is critical for its ezrin/radixin/moesin-directed subcellular targeting.
Serrador JM; Vicente-Manzanares M; Calvo J; Barreiro O; Montoya MC; Schwartz-Albiez R; Furthmayr H; Lozano F; Sánchez-Madrid F
J Biol Chem; 2002 Mar; 277(12):10400-9. PubMed ID: 11784723
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
18. The cytoplasmic tail of L-selectin interacts with members of the Ezrin-Radixin-Moesin (ERM) family of proteins: cell activation-dependent binding of Moesin but not Ezrin.
Ivetic A; Deka J; Ridley A; Ager A
J Biol Chem; 2002 Jan; 277(3):2321-9. PubMed ID: 11706008
[TBL] [Abstract][Full Text] [Related]
19. Ezrin mutants affecting dimerization and activation.
Chambers DN; Bretscher A
Biochemistry; 2005 Mar; 44(10):3926-32. PubMed ID: 15751968
[TBL] [Abstract][Full Text] [Related]
20. The 2.7 A crystal structure of the activated FERM domain of moesin: an analysis of structural changes on activation.
Edwards SD; Keep NH
Biochemistry; 2001 Jun; 40(24):7061-8. PubMed ID: 11401550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
